Seromycin

Operations will be halted in the coming months at the Chao Center for Industrial Pharmacy and Contract Manufacturing at the Purdue Research Park in West Lafayette.
The facility has not become self-sustaining during its five years of operation, according to Joseph Hornett, senior vice president, treasurer and chief operating officer of the Purdue Research Foundation, which owns and manages the research park.
The Chao Center is a pharmaceutical manufacturing facility that produces and distributes legacy and small-volume drugs.
The facility will continue manufacturing and distributing the multidrug-resistant tuberculosis drug Seromycin and other life-saving legacy drugs until new manufacturers are found.
http://www.jconline.com/article/20100424/NEWS09/100424005